Solubility Study of Acetylsalicylic Acid in Ethanol + Water Mixtures: Measurement, Mathematical Modeling, and Stability Discussion

Nokhodchi, Ali; Ghafourian, Taravat; Nashed, Nour; Asare-Addo, Kofi; Behboudi, Elmira; Sefid-Sefidehkhan, Yasaman; Zarghampour, Aynaz; Rahimpour, Elaheh; Jouyban, Abolghasem

doi:10.1208/s12249-021-02192-7

Cited by 7 publications

(1 citation statement)

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… [a] [ 43 ], [b] [ 44 ], [c] [ 45 ], [d] [ 46 ], [e] [ 47 ], [f] [ 48 ], [g] [ 49 ], [h] [ 42 ]. * Concentration of Drug (IC 50 ) that inhibited 50% of Cyclooxygenase (COX).…”

Section: Figurementioning

confidence: 99%

Acetylsalicylic Acid–Primus Inter Pares in Pharmacology

et al. 2022

View full text Add to dashboard Cite

Acetylsalicylic acid (ASA) is one of the first drugs to be obtained by synthesis while being the most used. It has experienced the longest lasting commercial success and is considered the most popular drug of the modern era. ASA, originally used as an anti-inflammatory medication, nowadays is predominantly used as an antiplatelet agent for prophylaxis in cardiac patients. Many studies show that the benefits of using ASA far outweigh the potential risk of side effects. With particular emphasis on the possibility of ASA repositioning for new therapies, extending the indications for use beyond the diseases from the spectrum of atherosclerotic diseases, such as cancer, requires shifting the benefit–risk ratio, although very good, even more towards safety. Interesting activities consisting not only of changing the formulation but also modifying the drug molecule seem to be an important goal of the 21st century. ASA has become a milestone in two important fields: pharmacy and medicine. For a pharmacist, ASA is a long-used drug for which individual indications are practically maintained. For a doctor, acetylsalicylic acid is primarily an antiplatelet drug that saves millions of lives of patients with coronary heart disease or after a stroke. These facts do not exempt us from improving therapeutic methods based on ASA, the main goal of which is to reduce the risk of side effects, as well as to extend effectiveness. Modified acetylsalicylic acid molecules already seem to be a promising therapeutic option.

show abstract

“… [a] [ 43 ], [b] [ 44 ], [c] [ 45 ], [d] [ 46 ], [e] [ 47 ], [f] [ 48 ], [g] [ 49 ], [h] [ 42 ]. * Concentration of Drug (IC 50 ) that inhibited 50% of Cyclooxygenase (COX).…”

Section: Figurementioning

confidence: 99%